CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Grant or award Director acquired 11,000 shares (grant or award)
- 4 Grant or award President acquired 207,201 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
- 4 Grant or award Director acquired 5,501 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,392 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 5,784 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,339 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 10,416 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 41,666 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 8,264 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 8,476 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,420 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 4,630 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 3,300 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 3,055 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 3,317 shares (grant or award)
Page 3 of 14 · 261 filings